p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics-Reference-Cited by-同舟云学术

p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics

Published:2022-01 Issue:1 Volume:15 Page:101276
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Ruiz-Patiño Alejandro,Rodríguez July,Cardona Andrés F.,Ávila Jenny,Archila Pilar,Carranza Hernán,Vargas Carlos,Otero Jorge,Arrieta Oscar,Zatarain-Barrón Lucia,Sotelo Carolina,Ordoñez Camila,García-Robledo Juan Esteban,Rojas Leonardo,Bermúdez Maritza,Gámez Tatiana,Mayorga Diana,Corrales Luis,Martín Claudio,Recondo Gonzalo,Mas Luis,Samtani Suraj,Ricaurte Luisa,Malapelle Umberto,Russo Alessandro,Barrón Feliciano,Santoyo Nicolas,Rolfo Christian,Rosell Rafael

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. The International Epidemiology of Lung Cancer: geographical distribution and secular trends;Youlden;J. Thorac. Oncol.,2008

2. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung;Rodenhuis;N. Engl. J. Med.,1987

3. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing;Ju;Genome Res.,2012

4. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014

5. Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer;Zhang;Sci. Rep.,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination;Cell Communication and Signaling;2024-06-12

2. Tumor heterogeneity and its impact on sotorasib response in a patient with non-small cell lung cancer;Oncology in Clinical Practice;2023-12-05

3. KRAS G12C-mutant driven non-small cell lung cancer (NSCLC);Critical Reviews in Oncology/Hematology;2023-12

4. Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis;Lung Cancer;2023-11

5. KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing;Lung Cancer;2023-10